Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Pharma-Bio Serv (PBSV) over the last 15 years, with Q4 2025 value amounting to 0.06%.

  • Pharma-Bio Serv's Return on Invested Capital rose 300.0% to 0.06% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.06%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.05% for FY2025, which is 400.0% up from last year.
  • Pharma-Bio Serv's Return on Invested Capital amounted to 0.06% in Q4 2025, which was up 300.0% from 0.05% recorded in Q3 2025.
  • Pharma-Bio Serv's 5-year Return on Invested Capital high stood at 0.08% for Q1 2021, and its period low was 0.25% during Q2 2022.
  • Over the past 5 years, Pharma-Bio Serv's median Return on Invested Capital value was 0.02% (recorded in 2025), while the average stood at 0.04%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first plummeted by -3100bps in 2022, then skyrocketed by 3100bps in 2023.
  • Pharma-Bio Serv's Return on Invested Capital (Quarter) stood at 0.2% in 2021, then soared by 130bps to 0.06% in 2022, then fell by -12bps to 0.05% in 2023, then crashed by -280bps to 0.1% in 2024, then surged by 35bps to 0.06% in 2025.
  • Its last three reported values are 0.06% in Q4 2025, 0.05% for Q3 2025, and 0.06% during Q2 2025.